Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region
- Status
- COMPLETED
- Phase
- N/A
Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study Evaluating MM-310 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CAR T Cells in Mesothelin Expressing Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Hysterectomy and OPPortunistic SAlpingectomy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
- Status
- RECRUITING
- Phase
- NA
Prognostic and Predictive Biomarkers in Ovarian Cancers
- Status
- RECRUITING
- Phase
- NA
Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125
- Status
- COMPLETED
- Phase
- N/A